Acquiring Decision Rules for Predicting Ames-Negative Hepatocarcinogens Using Chemical-Chemical Interactions
暂无分享,去创建一个
[1] Benjamin Haibe-Kains,et al. mRMRe: an R package for parallelized mRMR ensemble feature selection , 2013, Bioinform..
[2] Shinn-Ying Ho,et al. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties , 2007, Bioinform..
[3] Jon M. Maguire,et al. Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors. , 2012, Carcinogenesis.
[4] Ming-Tsang Wu,et al. Identification of Biomarkers for Esophageal Squamous Cell Carcinoma Using Feature Selection and Decision Tree Methods , 2013, TheScientificWorldJournal.
[5] Damian Szklarczyk,et al. STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..
[6] Errol Zeiger,et al. Historical perspective on the development of the genetic toxicity test battery in the United States , 2010, Environmental and molecular mutagenesis.
[7] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[8] Weida Tong,et al. BUILDING AN ORGAN-SPECIFIC CARCINOGENIC DATABASE FOR SAR ANALYSES , 2004, Journal of toxicology and environmental health. Part A.
[9] J. Ross Quinlan,et al. C4.5: Programs for Machine Learning , 1992 .
[10] Lei Chen,et al. Prediction of Cancer Drugs by Chemical-Chemical Interactions , 2014, PloS one.
[11] Chun-Wei Tung,et al. Prediction of Non-genotoxic Hepatocarcinogenicity Using Chemical-Protein Interactions , 2013, PRIB.
[12] E Zeiger,et al. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. , 1998, Regulatory toxicology and pharmacology : RTP.
[13] Shinn-Ying Ho,et al. POPISK: T-cell reactivity prediction using support vector machines and string kernels , 2011, BMC Bioinformatics.
[14] G. Williams,et al. The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[15] Weida Tong,et al. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships. , 2011, Chemical research in toxicology.
[16] Lei Chen,et al. Prediction of drug target groups based on chemical-chemical similarities and chemical-chemical/protein connections. , 2014, Biochimica et biophysica acta.
[17] Shinn-Ying Ho,et al. Computational identification of ubiquitylation sites from protein sequences , 2008, BMC Bioinformatics.
[18] Alessandro Giuliani,et al. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays , 2010, Expert opinion on drug metabolism & toxicology.
[19] T. Uehara,et al. Toxicogenomics discrimination of potential hepatocarcinogenicity of non‐genotoxic compounds in rat liver , 2012, Journal of applied toxicology : JAT.
[20] Y Hayashi,et al. Overview of genotoxic carcinogens and non-genotoxic carcinogens. , 1992, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[21] C. Tung. Prediction of pupylation sites using the composition of k-spaced amino acid pairs. , 2013, Journal of theoretical biology.